The Federal Trade Commission is gearing up to file lawsuits against three major U.S. health companies for their practices as middlemen in negotiating medication prices. The companies in question include UnitedHealth Group’s Optum Rx, CVS Health’s Caremark, and Cigna’s Express Scripts. These companies are connected to health insurers and are accused of inflating costs for
0 Comments
A bipartisan group of senators recently initiated a fresh attempt to prohibit members of Congress from engaging in stock trading. This proposal aims to address concerns regarding lawmakers profiting from privileged information and gaining an unfair advantage in the market. The proposed legislation would immediately prevent members of Congress, the president, and the vice president
0 Comments
Gratitude is often touted as a key component of a happy and fulfilling life. A recent study conducted by researchers from the Harvard TH Chan School of Public Health suggests that gratitude may also play a role in extending one’s lifespan. The study, which involved nearly 50,000 older nurses in the US, found a correlation
0 Comments
The Chinese exchange-traded funds (ETFs) have experienced a remarkable surge in growth over the past five years. According to Morningstar, the annual inflows to China ETFs have increased nearly fivefold in the last three years, reaching new highs consistently. In 2021, the total yearly inflows to Chinese ETFs amounted to 127.2 billion Chinese yuan, which
0 Comments
House Democrats recently gathered at their national party headquarters in Washington, DC, for a closed-door meeting to discuss a critical decision: whether to continue supporting President Joe Biden’s reelection bid or advocate for his withdrawal from the race. This meeting, held in the aftermath of Biden’s lackluster debate performance against former President Donald Trump, has
0 Comments
In a recent presentation at the American Society of Clinical Oncology (ASCO) meeting, a study showcased the potential benefits of using liposomal gemcitabine in combination with pembrolizumab for the treatment of advanced solid tumors. Charles Farber, MD, PhD, from Atlantic Hematology Oncology in Morristown, New Jersey, provided insights into the feasibility and tolerability of this
0 Comments